High-Yield Human Induced Pluripotent Stem Cell-Derived Monocytes and Macrophages Are Functionally Comparable With Primary Cells

Macrophages are pivotal effectors of host immunity and regulators of tissue homeostasis. Understanding of human macrophage biology has been hampered by the lack of reliable and scalable models for cellular and genetic studies. Human induced pluripotent stem cell (hiPSC)-derived monocytes and macroph...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in cell and developmental biology Vol. 9; p. 656867
Main Authors Cui, Di, Franz, Alexandra, Fillon, Sophie A., Jannetti, Linda, Isambert, Timo, Fundel-Clemens, Katrin, Huber, Heinrich J., Viollet, Coralie, Ghanem, Alexander, Niwa, Akira, Weigle, Bernd, Pflanz, Stefan
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 13.04.2021
Subjects
Online AccessGet full text
ISSN2296-634X
2296-634X
DOI10.3389/fcell.2021.656867

Cover

More Information
Summary:Macrophages are pivotal effectors of host immunity and regulators of tissue homeostasis. Understanding of human macrophage biology has been hampered by the lack of reliable and scalable models for cellular and genetic studies. Human induced pluripotent stem cell (hiPSC)-derived monocytes and macrophages, as an unlimited source of subject genotype-specific cells, will undoubtedly play an important role in advancing our understanding of macrophage biology and implication in human diseases. In this study, we present a fully optimized differentiation protocol of hiPSC-derived monocytes and granulocyte-macrophage colony-stimulating factor (GM-CSF) or macrophage colony-stimulating factor (M-CSF). We present characterization of iPSC-derived myeloid lineage cells at phenotypic, functional, and transcriptomic levels, in comparison with corresponding subsets of peripheral blood-derived cells. We also highlight the application of hiPSC-derived monocytes and macrophages as a gene-editing platform for functional validation in research and drug screening, and the study also provides a reference for cell therapies.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Hanne Scholz, University of Oslo, Norway; Federica Bono, University of Brescia, Italy
Edited by: Takashi Nakamura, Tohoku University, Japan
This article was submitted to Stem Cell Research, a section of the journal Frontiers in Cell and Developmental Biology
ISSN:2296-634X
2296-634X
DOI:10.3389/fcell.2021.656867